Impact of Left Atrial Appendage Closure on Physical Capacity.
NCT03085693 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2022-11-01
Summary
Closure of the left atrial appendage in patients with atrial fibrillation and risk for stroke is a increasing technology leading to exclusion of the left atrial appendage volume from the blood circulation and therefore protects from cardioembolic strokes- It is unclear if the volume reduction of the left atrium leads to a change in exercise capacity or Quality of life.
Conditions
Sponsors & Collaborators
-
University of Jena
collaborator OTHER -
University of Leipzig
lead OTHER
Principal Investigators
-
Sven Möbius-Winkler, MD, PhD · University of Jena
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2022-12-31
- Completion
- 2023-11-30
Countries
- Germany
Study Locations
More Related Trials
-
Effect of Left Atrial Appendage Excision on Procedure Outcome in Patients With Persistent and Long-standing Persistent Atrial Fibrillation Undergoing Surgical Ablation
NCT02562391 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Safety and Efficacy of a Left Atrial Appendage Occulder
NCT02937025 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
NCT04676880 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Left Atrial Appendage Electrical Isolation in Persistent Atrial Fibrillation
NCT04897204 ·Status: UNKNOWN ·Phase: NA
-
Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke
NCT04479722 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI
NCT02492230 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device
NCT06099106 ·Status: RECRUITING ·Phase: NA
-
Effects of Left Atrial Appendage Occlusion
NCT00510900 ·Status: WITHDRAWN
-
Left Atrial Appendage Occlusion and Biomarker Evaluation
NCT02985463 ·Status: UNKNOWN
-
Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease
NCT05204212 ·Status: RECRUITING ·Phase: NA
-
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
NCT03795298 ·Status: COMPLETED ·Phase: NA
-
Multimodality Evaluation of LAA Leaks Arising After Incomplete LAAC: Insights From the LAA-Leak Registry
NCT05131308 ·Status: COMPLETED
-
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events
NCT04559243 ·Status: RECRUITING
-
REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion
NCT03279406 ·Status: COMPLETED
-
Registry on WATCHMAN Outcomes in Real-Life Utilization
NCT01972282 ·Status: COMPLETED
-
Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation: A Safety and Feasibility Study
NCT02028130 ·Status: UNKNOWN ·Phase: NA
-
Left Atrial Appendage Closure Registry of Henri Mondor Hospital
NCT05565209 ·Status: RECRUITING
-
Safety and Effectiveness of Left Atrial Appendage Occlusion
NCT00567515 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET
NCT05464511 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Catheter Ablation vs. Medical Therapy in Congested Hearts With AF
NCT02686749 ·Status: TERMINATED ·Phase: PHASE4
-
Pulsed Field Ablation During Left Atrial Appendage Occlusion: A Randomised Controlled Trial
NCT06334250 ·Status: WITHDRAWN ·Phase: NA
-
Procedure RElated Outcomes With the Watchman FLX Left Atrial Appendage Closure Device
NCT03339193 ·Status: WITHDRAWN
-
Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast Asia Observational Study
NCT05687591 ·Status: COMPLETED
-
Stroke Feasibility Study
NCT01997905 ·Status: COMPLETED ·Phase: PHASE1/PHASE2